These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29522642)

  • 1. Pyridine-substituted thiazolylphenol derivatives: Synthesis, modeling studies, aromatase inhibition, and antiproliferative activity evaluation.
    Ertas M; Sahin Z; Berk B; Yurttas L; Biltekin SN; Demirayak S
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700272. PubMed ID: 29522642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on non-steroidal inhibitors of aromatase enzyme; 4-(aryl/heteroaryl)-2-(pyrimidin-2-yl)thiazole derivatives.
    Sahin Z; Ertas M; Berk B; Biltekin SN; Yurttas L; Demirayak S
    Bioorg Med Chem; 2018 May; 26(8):1986-1995. PubMed ID: 29525337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, Aromatase Inhibitory, Antiproliferative and Molecular Modeling Studies of Functionally Diverse D-Ring Pregnenolone Pyrazoles.
    Banday AH; Saeed BA; Al-Masoudi NA
    Anticancer Agents Med Chem; 2021; 21(13):1671-1679. PubMed ID: 33238853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, in vitro and in silico studies of some novel thiazole-dihydrofuran derivatives as aromatase inhibitors.
    Osmaniye D; Görgülü Ş; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
    Bioorg Chem; 2021 Sep; 114():105123. PubMed ID: 34214753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and docking study of benzimidazole-triazolothiadiazine hybrids as aromatase inhibitors.
    Acar Çevik U; Sağlık BN; Osmaniye D; Levent S; Kaya Çavuşoğlu B; Karaduman AB; Özkay Y; Kaplancıklı ZA
    Arch Pharm (Weinheim); 2020 May; 353(5):e2000008. PubMed ID: 32159244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of novel synthesized thiazole derivatives as potential aromatase inhibitors against breast cancer.
    Fayad E; Binjawhar DN; Ageeli AA; Alshaya DS; Elsaid FG; Mahmoud AY; Radwan EM; Elian Sophy MA; Mahdy AR
    Future Med Chem; 2024; 16(8):707-721. PubMed ID: 38488019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, investigation of biological effects and in silico studies of new benzimidazole derivatives as aromatase inhibitors.
    Sağlık BN; Şen AM; Evren AE; Çevik UA; Osmaniye D; Kaya Çavuşoğlu B; Levent S; Karaduman AB; Özkay Y; Kaplancıklı ZA
    Z Naturforsch C J Biosci; 2020 Sep; 75(9-10):353-362. PubMed ID: 32681791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent aromatase inhibitors and molecular mechanism of inhibitory action.
    Kang H; Xiao X; Huang C; Yuan Y; Tang D; Dai X; Zeng X
    Eur J Med Chem; 2018 Jan; 143():426-437. PubMed ID: 29202405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New enantioenriched β-indolyl ketones as aromatase inhibitors: Unraveling heme-ligand interactions by MD simulation and MMPBSA analysis.
    Pasha MH; Gondal HY; Munir S; Alhussain SA; Zaki MEA
    Arch Pharm (Weinheim); 2024 Jul; 357(7):e2400010. PubMed ID: 38578079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis, and Biological Evaluation of New Azole Derivatives as Potent Aromatase Inhibitors with Potential Effects against Breast Cancer.
    Kalalinia F; Jouya M; Komachali AK; Aboutourabzadeh SM; Karimi G; Behravan J; Abnous K; Etemad L; Kamali H; Hadizadeh F
    Anticancer Agents Med Chem; 2018; 18(7):1016-1024. PubMed ID: 29336269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, molecular modeling, DFT, ADME and biological evaluation studies of some new 1,3,4-oxadiazole linked benzimidazoles as anticancer agents and aromatase inhibitors.
    Acar Çevik U; Celik I; Işık A; Ahmad I; Patel H; Özkay Y; Kaplancıklı ZA
    J Biomol Struct Dyn; 2023 Mar; 41(5):1944-1958. PubMed ID: 35037830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Multifunctional Hybrid Analogs for Stilbenes, Chalcones and Flavanones.
    Cagir A; Odaci B; Varol M; Akcok I; Okur O; Koparal AT
    Anticancer Agents Med Chem; 2018 Feb; 17(14):1915-1923. PubMed ID: 28554313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, Docking Studies and Biological Activity of New Benzimidazole- Triazolothiadiazine Derivatives as Aromatase Inhibitor.
    Acar Çevik U; Kaya Çavuşoğlu B; Sağlık BN; Osmaniye D; Levent S; Ilgın S; Özkay Y; Kaplancıklı ZA
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32252458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, modeling studies and biological evaluation of pyrazole derivatives linked to oxime and nitrate moieties as nitric oxide donor selective COX-2 and aromatase inhibitors with dual anti-inflammatory and anti-neoplastic activities.
    A A Fadaly W; A M M Elshaier Y; T M Nemr M; R A Abdellatif K
    Bioorg Chem; 2023 May; 134():106428. PubMed ID: 36893546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of 2,4-di-p-phenolyl-6-2-furanyl-pyridine as a potent topoisomerase II poison.
    Karki R; Park C; Jun KY; Kadayat TM; Lee ES; Kwon Y
    Eur J Med Chem; 2015 Jan; 90():360-78. PubMed ID: 25437622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and Pharmacophore Study of Triazole Analogues as Aromatase Inhibitors.
    Banjare L
    Anticancer Agents Med Chem; 2024; 24(4):288-303. PubMed ID: 37921212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
    Ahmad I; Shagufta
    Eur J Med Chem; 2015 Sep; 102():375-86. PubMed ID: 26301554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combating breast cancer with non-steroidal aromatase inhibitors (NSAIs): Understanding the chemico-biological interactions through comparative SAR/QSAR study.
    Adhikari N; Amin SA; Saha A; Jha T
    Eur J Med Chem; 2017 Sep; 137():365-438. PubMed ID: 28622580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers.
    Ghorab MM; Alsaid MS; Al-Ansary GH; Abdel-Latif GA; Abou El Ella DA
    Eur J Med Chem; 2016 Nov; 124():946-958. PubMed ID: 27770735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New azolyl-derivatives as multitargeting agents against breast cancer and fungal infections: synthesis, biological evaluation and docking study.
    Maccallini C; Gallorini M; Sisto F; Akdemir A; Ammazzalorso A; De Filippis B; Fantacuzzi M; Giampietro L; Carradori S; Cataldi A; Amoroso R
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1632-1645. PubMed ID: 34289751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.